C-reactive protein and P-wave in hypertensive patients after conversion of atrial fibrillation

Andrea Mazza1, Maria G Bendini, Marco Cristofori

  • 1Cardiology Division, Santa Maria della Stella Hospital, Orvieto, Italy.

Insights

High-sensitivity C-reactive protein (hs-C-reactive protein) is linked to prolonged P-wave duration and dispersion in hypertensive patients post-atrial fibrillation conversion. This suggests subclinical inflammation may impact atrial activation.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Inflammation Markers

Background:

  • Atrial fibrillation recurrence is a clinical concern.
  • P-wave duration and dispersion are ECG markers of atrial activation.
  • High-sensitivity C-reactive protein (hs-C-reactive protein) is an inflammation marker.

Purpose of the Study:

  • To investigate the association between hs-C-reactive protein and P-wave parameters (P maximum/P dispersion) in hypertensive patients after atrial fibrillation conversion.
  • To determine if hs-C-reactive protein can predict delayed or inhomogeneous atrial activation.

Main Methods:

  • 92 hypertensive patients undergoing cardioversion for atrial fibrillation were enrolled.
  • Hs-C-reactive protein levels were measured before cardioversion.
  • 12-lead ECGs were recorded immediately after sinus rhythm restoration to assess P-wave duration and dispersion.

Main Results:

  • Elevated hs-C-reactive protein (>0.30 mg/dl) was significantly associated with increased P maximum (>120 ms) and P dispersion (>40 ms) in univariate and multivariate analyses.
  • Male sex was also associated with increased P maximum.
  • Hs-C-reactive protein was the sole predictor for increased P dispersion in multivariate analysis.

Conclusions:

  • Hs-C-reactive protein is associated with prolonged P-wave duration and dispersion in hypertensive patients post-atrial fibrillation conversion.
  • Subclinical inflammation, indicated by hs-C-reactive protein, may contribute to delayed and inhomogeneous atrial activation in these patients.
  • These findings highlight the potential role of inflammation in atrial remodeling and dysfunction.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...